Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05670847 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Exogenous Ketone Esters for Drug Resistant Epilepsy

Study acronym: EKEDRE
StatusRecruiting
PhasePhase 2/3
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated November 27, 2024 (before its estimated June 30, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary completion date: Jun 30, 2024 to Jun 30, 2025
    • Study completion date: Jul 1, 2024 to Jul 1, 2025
    v4
  2. Re-verified, no change to tracked fieldsv3
  3. Trial status: Not Yet Recruiting to Recruiting
    • Site details revised
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Sohag University
498 trials monitored
See 2 trials at risk
Epilepsy
769 trials monitored
See 48 trials at risk
This study aims to investigate the efficacy of add-on exogenous ketone esters for treating children with drug-resistant epilepsy
Trial Details
NCT Number NCT05670847
Lead Sponsor Sohag University
Conditions
(from sponsor)		 Drug Resistant Epilepsy
Related terms Drug Resistant Epilepsy
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov